Mannatech
This article was originally published in The Tan Sheet
Executive Summary
Founder and Chairman Sam Caster unanimously appointed CEO by the Board of Directors April 15. He succeeds CEO and Board Member Robert Henry, who will continue to work with the firm as a consultant during the transition...
You may also be interested in...
Business/Finance In Brief
Twinlab: Discontinuation of ephedra sales accounted for 17.1% drop in Q1 revenue to $37.7 mil., Twinlab says in May 15 1earnings release. Hauppauge, N.Y.-based firm recorded net loss of $3.7 mil. in first quarter, compared to net income of $3.7 mil. in Q1 2002. Loss includes "restructuring charges of $1 mil. relating to the facilities consolidation and a gain on the sale of the assets of Bronson Labs" of $800,000. Firm points out net income in Q1 2002 included federal income tax benefit of $6.9 mil. Twinlab has classified its mortgage agreement for Utah facility, borrowings under revolving credit facility as "current liabilities" and is working to amend mortgage agreement, find alternatives to RCF...
Vanda Comes Up Empty Handed As US Supreme Court Denies Hetlioz Appeal
Vanda looks likely to have to face up to unimpeded US generic competition to its core Hetlioz brand, after a further denial in its litigation against ANDA sponsors Teva and Apotex.
EU: Good News For IVDs And For Future Transparency Of Medtech Compliance
The IVD industry has long been awaiting a further extension of the deadlines for compliance with the IVD Regulation and for the launch date of the Eudamed database to be brought forward.